|
|
Count
|
%
|
Count
|
%
|
Count
|
%
|
Count
|
%
|
Count
|
%
|
|
| Total |
21 676 |
100 |
2227 |
10.3% |
3424 |
15.8% |
6432 |
29.7% |
9593 |
44.3% |
|
| Patient Age |
|
|
|
|
|
|
|
|
|
|
|
| 0–19 |
121 |
0.6% |
69 |
3.1% |
36 |
1.1% |
11 |
0.2% |
5 |
0.1% |
|
| 20–29 |
588 |
2.7% |
289 |
13.0% |
175 |
5.1% |
82 |
1.3% |
42 |
0.4% |
|
| 30–39 |
1256 |
5.8% |
511 |
22.9% |
366 |
10.7% |
224 |
3.5% |
155 |
1.6% |
|
| 40–49 |
2045 |
9.4% |
529 |
23.8% |
616 |
18.0% |
517 |
8.0% |
383 |
4.0% |
|
| 50–59 |
3540 |
16.3% |
599 |
26.9% |
980 |
28.6% |
1151 |
17.9% |
810 |
8.4% |
|
| 60–69 |
4744 |
21.9% |
230 |
10.3% |
816 |
23.8% |
1456 |
22.6% |
2242 |
23.4% |
|
| 70–79 |
4399 |
20.3% |
0 |
0.0% |
213 |
6.2% |
1125 |
17.5% |
3061 |
31.9% |
|
| 80–89 |
3525 |
16.3% |
0 |
0.0% |
154 |
4.5% |
1188 |
18.5% |
2183 |
22.8% |
|
| 90+ |
1458 |
6.7% |
0 |
0.0% |
68 |
2.0% |
678 |
10.5% |
712 |
7.4% |
<.001 |
|
Age in years (mean/std dev)
|
64.9
|
17.2
|
43.1
|
13.2
|
54.1
|
15.3
|
67.6
|
16.0
|
72.0
|
12.7
|
<.001 |
| Gender |
|
|
|
|
|
|
|
|
|
|
|
| Female |
10 234 |
47.2% |
937 |
42.1% |
1477 |
43.1% |
2979 |
46.3% |
4841 |
50.5% |
|
| Male |
11 442 |
52.8% |
1290 |
57.9% |
1947 |
56.9% |
3453 |
53.7% |
4752 |
49.5% |
<.001 |
| Discharge Status |
|
|
|
|
|
|
|
|
|
|
|
| Expired |
4936 |
22.8% |
83 |
3.7% |
387 |
11.3% |
1446 |
22.5% |
3020 |
31.5% |
|
| Home |
9080 |
41.9% |
1793 |
80.5% |
2202 |
64.3% |
2532 |
39.4% |
2553 |
26.6% |
|
| Home health |
2001 |
9.2% |
97 |
4.4% |
240 |
7.0% |
603 |
9.4% |
1061 |
11.1% |
|
| Hospice |
729 |
3.4% |
8 |
0.4% |
54 |
1.6% |
272 |
4.2% |
395 |
4.1% |
|
| LTC |
231 |
1.1% |
9 |
0.4% |
19 |
0.6% |
82 |
1.3% |
121 |
1.3% |
|
| Other |
362 |
1.7% |
68 |
3.1% |
71 |
2.1% |
107 |
1.7% |
116 |
1.2% |
|
| Rehab |
426 |
2.0% |
17 |
0.8% |
58 |
1.7% |
132 |
2.1% |
219 |
2.3% |
|
| SNF or ICF |
2571 |
11.9% |
43 |
1.9% |
183 |
5.3% |
814 |
12.7% |
1531 |
16.0% |
|
| Transfer |
708 |
3.3% |
76 |
3.4% |
119 |
3.5% |
229 |
3.6% |
284 |
3.0% |
|
| Missing/unknown |
632 |
2.9% |
33 |
1.5% |
91 |
2.7% |
215 |
3.3% |
293 |
3.1% |
<.001 |
| Primary Payer |
|
|
|
|
|
|
|
|
|
|
|
| Commercial |
5752 |
26.5% |
912 |
41.0% |
1420 |
41.5% |
1743 |
27.1% |
1677 |
17.5% |
|
| Medicaid |
2772 |
12.8% |
603 |
27.1% |
673 |
19.7% |
755 |
11.7% |
741 |
7.7% |
|
| Medicare |
10 889 |
50.2% |
159 |
7.1% |
716 |
20.9% |
3291 |
51.2% |
6723 |
70.1% |
|
| Other |
1142 |
5.3% |
251 |
11.3% |
314 |
9.2% |
315 |
4.9% |
262 |
2.7% |
|
| Missing/unknown |
1121 |
5.2% |
302 |
13.6% |
301 |
8.8% |
328 |
5.1% |
190 |
2.0% |
<.001 |
| Medicaid |
|
|
|
|
|
|
|
|
|
|
|
| Medicaid as any payer |
5700 |
26.3% |
701 |
31.5% |
952 |
27.8% |
1553 |
24.1% |
2494 |
26.0% |
<.001 |
| Statin/ACE/ARBs Medications Administered in Hospital |
|
|
|
|
|
|
|
|
|
|
|
| Statins |
5313 |
24.5% |
87 |
3.9% |
425 |
12.4% |
1659 |
25.8% |
3142 |
32.85% |
<.001 |
| ACE inhibitors |
1472 |
6.8% |
5 |
0.2% |
127 |
3.7% |
513 |
8.0% |
827 |
8.6% |
<.001 |
| ARBs |
1277 |
5.9% |
4 |
0.2% |
100 |
2.9% |
405 |
6.3% |
768 |
8.0% |
<.001 |
| CDC Comorbid Risk Factors |
|
|
|
|
|
|
|
|
|
|
|
| Age >65 |
11 695 |
54.0% |
0 |
0.0% |
600 |
17.5% |
3564 |
55.4% |
7531 |
78.5% |
<.001 |
| Chronic lung disease |
4654 |
21.5% |
0 |
0.0% |
336 |
9.8% |
613 |
9.5% |
3705 |
38.6% |
<.001 |
| Moderate to severe asthma |
100 |
0.5% |
0 |
0.0% |
0 |
0.0% |
14 |
0.2% |
86 |
0.9% |
<.001 |
| Severe heart disease |
12 000 |
55.4% |
0 |
0.0% |
756 |
22.1% |
3854 |
59.9% |
7390 |
77.0% |
<.001 |
| Immunocompromised |
1997 |
9.2% |
0 |
0.0% |
155 |
4.5% |
314 |
4.9% |
1528 |
15.9% |
<.001 |
| Obesity |
3029 |
14.0% |
0 |
0.0% |
346 |
10.1% |
654 |
10.2% |
2029 |
21.2% |
<.001 |
| Diabetes |
9167 |
42.3% |
0 |
0.0% |
393 |
11.5% |
1765 |
27.4% |
7009 |
73.1% |
<.001 |
| CKD with dialysis |
1269 |
5.9% |
0 |
0.0% |
8 |
0.2% |
113 |
1.8% |
1148 |
12.0% |
<.001 |
| Liver disease |
936 |
4.3% |
0 |
0.0% |
88 |
2.6% |
179 |
2.8% |
669 |
7.0% |
<.001 |
| Hypertension |
14 757 |
68.1% |
0 |
0.0% |
1195 |
34.9% |
4887 |
76.0% |
8675 |
90.4% |
<.001 |
| Other Comorbidities |
|
|
|
|
|
|
|
|
|
|
|
| CKD (any stage) |
1470 |
6.8% |
28 |
1.3% |
181 |
5.3% |
113 |
1.8% |
1148 |
12.0% |
<.001 |
| Hemoptysis |
164 |
0.8% |
14 |
0.6% |
31 |
0.9% |
46 |
0.7% |
73 |
0.8% |
0.649 |
| Hypothyroidism |
2260 |
10.4% |
101 |
4.5% |
223 |
6.5% |
688 |
10.7% |
1248 |
13.0% |
<.001 |
| DNR Status |
5301 |
24.5% |
59 |
2.6% |
342 |
10.0% |
1775 |
27.6% |
3125 |
32.6% |
<.001 |
| Charlson Comorbidities |
|
|
|
|
|
|
|
|
|
|
|
| Myocardial infarction |
1780 |
8.2% |
0 |
0.0% |
83 |
2.4% |
504 |
7.8% |
1193 |
12.4% |
<.001 |
| Congestive heart failure |
3479 |
16.1% |
0 |
0.0% |
92 |
2.7% |
786 |
12.2% |
2601 |
27.1% |
<.001 |
| Peripheral vascular disease |
1030 |
4.8% |
5 |
0.2% |
56 |
1.6% |
288 |
4.5% |
681 |
7.1% |
<.001 |
| Cerebrovascular disease |
1547 |
7.1% |
26 |
1.2% |
118 |
3.4% |
470 |
7.3% |
933 |
9.7% |
<.001 |
| Dementia |
1659 |
7.7% |
26 |
1.2% |
154 |
4.5% |
604 |
9.4% |
875 |
9.1% |
<.001 |
| Chronic pulmonary disease |
4654 |
21.5% |
0 |
0.0% |
336 |
9.8% |
613 |
9.5% |
3705 |
38.6% |
<.001 |
| Connective tissue disease |
489 |
2.3% |
7 |
0.3% |
34 |
1.0% |
105 |
1.6% |
343 |
3.6% |
<.001 |
| Peptic ulcer disease |
160 |
0.7% |
9 |
0.4% |
10 |
0.3% |
36 |
0.6% |
105 |
1.1% |
<.001 |
| Mild liver disease |
247 |
1.1% |
0 |
0.0% |
20 |
0.6% |
40 |
0.6% |
187 |
1.9% |
<.001 |
| Diabetes without end-organ damage |
5057 |
23.3% |
0 |
0.0% |
248 |
7.2% |
1073 |
16.7% |
3736 |
38.9% |
<.001 |
| Diabetes with end-organ damage |
3930 |
18.1% |
0 |
0.0% |
40 |
1.2% |
397 |
6.2% |
3493 |
36.4% |
<.001 |
| Hemiplegia |
277 |
1.3% |
17 |
0.8% |
46 |
1.3% |
83 |
1.3% |
131 |
1.4% |
0.146 |
| Moderate or severe renal disease |
5360 |
24.7% |
33 |
1.5% |
208 |
6.1% |
1269 |
19.7% |
3850 |
40.1% |
<.001 |
| Tumor without metastases |
959 |
4.4% |
0 |
0.0% |
55 |
1.6% |
116 |
1.8% |
788 |
8.2% |
<.001 |
| Moderate or severe liver disease |
155 |
0.7% |
0 |
0.0% |
12 |
0.4% |
34 |
0.5% |
109 |
1.1% |
<.001 |
| Metastatic solid tumor |
265 |
1.2% |
0 |
0.0% |
23 |
0.7% |
38 |
0.6% |
204 |
2.1% |
<.001 |
| AIDS |
149 |
0.7% |
0 |
0.0% |
20 |
0.6% |
27 |
0.4% |
102 |
1.1% |
<.001 |
|
Charlson Comorbidity Index (mean/sd)
|
2.3
|
2.5
|
0.1
|
0.4
|
0.7
|
1.3
|
1.5
|
1.7
|
3.8
|
2.6
|
<.001 |